U.S. federal trademark · Serial No. 77163274 · Reg. No. 3958016
Chemical or biological agents which cause progenitor cells to differentiate into cartilage tissue lineage cells or which cause progenitor cells to differentiate into bone marrow stroma tissue lineage cells, for medical use; pharmaceutical compositions, namely, mesenchymal stem cell (MSC) compositions for the regeneration of cardiac tissue and the treatment of heart disease; pharmaceutical compositions containing mesenchymal stem cells and their bone lineage committed descendants which may be combined with a matrix for bone repair and regeneration; cells for medical use for regeneration of human tissue, namely, bone, cartilage, marrow, muscle, adipose, tissue, and tendon composition; pharmaceutical composition containing mesenchymal stem cells which may be administered intravenously for immune response modulation and to affect tissue repair in treating immune and inflammatory disease
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.